Human Induced Pluripotent Stem Cells as a Disease Model System for Heart Failure.

Current Heart Failure Reports
Anton Deicher, Timon Seeger

Abstract

Heart failure is among the most prevalent disease complexes overall and is associated with high morbidity and mortality. The underlying aetiology is manifold including coronary artery disease, genetic alterations and mutations, viral infections, adverse immune responses, and cardiac toxicity. To date, no specific therapies have been developed despite notable efforts. This can especially be attributed to hurdles in translational research, mainly due to the lack of proficient models of heart failure limited translation of therapeutic approaches from bench to bedside. Human induced pluripotent stem cells (hiPSCs) are rising in popularity, granting the ability to divide infinitely, to hold human, patient-specific genome, and to differentiate into any human cell, including cardiomyocytes (hiPSC-CMs). This brings magnificent promise to cardiological research, providing the possibility to recapitulate cardiac diseases in a dish. Advances in yield, maturity, and in vivo resemblance due to straightforward, low-cost protocols, high-throughput approaches, and complex 3D cultures have made this tool widely applicable. In recent years, hiPSC-CMs have been used to model a wide variety of cardiac diseases, bringing along the possibility to no...Continue Reading

References

Oct 5, 2001·IEEE Transactions on Bio-medical Engineering·J T RubinsteinP J Abbas
Oct 17, 2008·Physiological Reviews·Heping Cheng, W J Lederer
May 23, 2012·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Filomain NguemoJürgen Hescheler
Jun 13, 2012·Physiology·Robert David, Wolfgang-Michael Franz
Jan 10, 2013·Journal of Cardiovascular Translational Research·Masayuki Yazawa, Ricardo E Dolmetsch
Jan 29, 2013·Nature·Changsung KimHuei-Sheng Vincent Chen
Feb 13, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Tsukasa KamakuraTakeshi Kimura
Aug 31, 2013·Circulation Research·Min Luo, Mark E Anderson
Oct 11, 2013·Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society·Akimasa TakeuchiYasuhiko Jimbo
Nov 1, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Irene C TurnbullKevin D Costa
Nov 26, 2013·Biomaterials·Zhen MaKevin E Healy
Apr 17, 2014·Journal of Molecular and Cellular Cardiology·Xiulan YangCharles E Murry
May 3, 2014·Journal of Cardiovascular Pharmacology·László NagyZoltán Papp
Mar 6, 2015·Critical Reviews in Biotechnology·Sonia ZiaAlexander M Seifalian
May 15, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Jian-Yan WenHuei-Sheng Vincent Chen
Sep 30, 2015·Proceedings of the National Academy of Sciences of the United States of America·Alexandre J S RibeiroBeth L Pruitt
Mar 5, 2016·Nature Reviews. Cardiology·Boback Ziaeian, Gregg C Fonarow
Apr 27, 2016·Cell·Jennifer DavisJeffery D Molkentin
May 18, 2016·Journal of Pharmacological Sciences·Fernando López-RedondoKenji Yasuda
May 12, 2017·Nature Protocols·Kaja BreckwoldtArne Hansen
Jun 3, 2017·Cellular and Molecular Life Sciences : CMLS·E GiacomelliM Bellin
Jun 10, 2017·Circulation Research·Yoshinori Yoshida, Shinya Yamanaka

❮ Previous
Next ❯

Citations

Apr 16, 2021·Cardiovascular Drugs and Therapy·Haocheng LuMinerva T Garcia-Barrio

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
force measurement
biopsies
flow cytometry

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.